Aliases & Classifications for Taeniasis

MalaCards integrated aliases for Taeniasis:

Name: Taeniasis 12 72 14
Infection by Taeniarhynchus Saginatus 12
Taenia Saginata Infectious Disease 12
Taenia Saginata Infection 69
Beef Tapeworm Infection 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0050596
ICD10 32 B68.1 B68 B68.9
ICD9CM 34 123.2
SNOMED-CT 64 69163003
UMLS 69 C0152073

Summaries for Taeniasis

Disease Ontology : 12 A parasitic helminthiasis infectious disease that has material basis in Taenia solium or has material basis in Taenia saginata, which are transmitted_by ingestion of undercooked contaminated meat.

MalaCards based summary : Taeniasis, also known as infection by taeniarhynchus saginatus, is related to cysticercosis and ancylostomiasis. An important gene associated with Taeniasis is MT-CO1 (Mitochondrially Encoded Cytochrome C Oxidase I), and among its related pathways/superpathways is Allograft rejection. The drugs Albendazole and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and colon.

Wikipedia : 72 Taeniasis is a parasitic disease due to infection with tapeworms belonging to the genus Taenia. The two... more...

Related Diseases for Taeniasis

Diseases related to Taeniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 163)
# Related Disease Score Top Affiliating Genes
1 cysticercosis 33.0 MT-CO1 MT-ND1 RTP1 TACSTD2
2 ancylostomiasis 30.5 CD40LG MT-CO1
3 hymenolepiasis 30.2 CD79A MT-CO1
4 echinococcosis 29.9 CD40LG CD79A IL10 MT-CO1 MT-ND1
5 schistosomiasis 29.7 CD40LG CD79A IL10
6 clonorchiasis 29.6 CD79A CTSL IL10
7 parasitic helminthiasis infectious disease 28.7 CD40LG CD79A CTSL IL10 MT-CO1 MT-ND1
8 deafness, nonsyndromic sensorineural, mitochondrial 10.6 MT-CO1 MT-ND1
9 fasciolopsiasis 10.5 CD40LG CTSL
10 gnathomiasis 10.4 CTSL MT-CO1
11 ross river fever 10.4 CD40LG IL10
12 coenurosis 10.4 MT-CO1 MT-ND1 TACSTD2
13 necrotizing ulcerative gingivitis 10.4 CD40LG IL10
14 selective igg deficiency disease 10.4 CD40LG CD79A
15 c1q nephropathy 10.4 CD40LG CD79A
16 meningovascular neurosyphilis 10.4 CD40LG CD79A
17 alpha chain disease 10.4 CD40LG CD79A
18 brill-zinsser disease 10.4 CD40LG CD79A
19 exudative glomerulonephritis 10.4 CD40LG CD79A
20 cork-handlers' disease 10.4 CD40LG CD79A
21 salpingo-oophoritis 10.4 CD40LG CD79A
22 early yaws 10.4 CD40LG CD79A
23 ventilation pneumonitis 10.4 CD40LG CD79A
24 chronic interstitial cystitis 10.4 CD40LG CD79A
25 axillary adenitis 10.4 CD40LG CD79A
26 cryofibrinogenemia 10.4 CD40LG CD79A
27 trichostrongyloidiasis 10.4 CD40LG CD79A
28 subacute bacterial endocarditis 10.4 CD40LG CD79A
29 heterophyiasis 10.4 CD40LG CD79A
30 immunoglobulin g deficiency 10.4 CD40LG CD79A
31 orbital granuloma 10.4 CD40LG CD79A
32 transient hypogammaglobulinemia of infancy 10.4 CD40LG CD79A
33 hyperglobulinemic purpura 10.4 CD40LG CD79A
34 gastroduodenitis 10.4 CD40LG CD79A
35 bacterial conjunctivitis 10.4 CD40LG CD79A
36 heavy chain disease 10.4 CD40LG CD79A
37 ophthalmia neonatorum 10.4 CD40LG CD79A
38 parotid disease 10.3 CD40LG CD79A
39 cerebral arteritis 10.3 CD40LG CD79A
40 selective immunoglobulin deficiency disease 10.3 CD40LG CD79A
41 geniculate herpes zoster 10.3 CD40LG CD79A
42 erythema elevatum diutinum 10.3 CD40LG CD79A
43 fallopian tube disease 10.3 CD40LG CD79A
44 hyperimmunoglobulin syndrome 10.3 CD40LG CD79A
45 congenital syphilis 10.3 CD40LG CD79A
46 polyclonal hypergammaglobulinemia 10.3 CD40LG CD79A
47 monoclonal paraproteinemia 10.3 CD40LG CD79A
48 salpingitis 10.3 CD40LG CD79A
49 ocular toxoplasmosis 10.3 CD40LG CD79A
50 buruli ulcer 10.3 CD40LG IL10

Graphical network of the top 20 diseases related to Taeniasis:



Diseases related to Taeniasis

Symptoms & Phenotypes for Taeniasis

Drugs & Therapeutics for Taeniasis

Drugs for Taeniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 39)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Albendazole Approved, Vet_approved Phase 3,Phase 2 54965-21-8 2082
2
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
3
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
4
Praziquantel Approved, Investigational, Vet_approved Phase 2, Phase 3 55268-74-1 4891
5
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
6
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
7 tannic acid Approved, Nutraceutical Phase 3
8 Anthelmintics Phase 3,Phase 2,Phase 1
9 Anti-Infective Agents Phase 3,Phase 2,Phase 1
10 Antimitotic Agents Phase 3,Phase 2
11 Antiparasitic Agents Phase 3,Phase 2,Phase 1
12 Antiprotozoal Agents Phase 3,Phase 2
13 Antacids Phase 3
14 Antiemetics Phase 3,Phase 2
15 Anti-Inflammatory Agents Phase 3,Phase 2
16 Antineoplastic Agents, Hormonal Phase 3,Phase 2
17 Anti-Ulcer Agents Phase 3
18 Autonomic Agents Phase 3,Phase 2
19 BB 1101 Phase 3,Phase 2
20 Dexamethasone acetate Phase 3,Phase 2 1177-87-3
21 Gastrointestinal Agents Phase 3,Phase 2
22 glucocorticoids Phase 3,Phase 2
23 HIV Protease Inhibitors Phase 3,Phase 2
24 Hormone Antagonists Phase 3,Phase 2
25 Hormones Phase 3,Phase 2
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
27 Peripheral Nervous System Agents Phase 3,Phase 2
28
protease inhibitors Phase 3,Phase 2
29 Proton pump inhibitors Phase 3
30 Anticonvulsants Phase 2, Phase 3
31 Carbonic Anhydrase Inhibitors Phase 2, Phase 3
32 diuretics Phase 2, Phase 3
33 Natriuretic Agents Phase 2, Phase 3
34 Benzimidazole Experimental, Investigational Phase 1 51-17-2
35
Oxfendazole Phase 1 53716-50-0 40854
36
Phenytoin Approved, Vet_approved 57-41-0 1775
37 Niclosamide Approved, Investigational, Vet_approved 50-65-7 4477
38 Diuretics, Potassium Sparing
39 Sodium Channel Blockers

Interventional clinical trials:

(show all 20)

# Name Status NCT ID Phase Drugs
1 Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Completed NCT02243644 Phase 3 7 days of albendazole 15 mg/kg/day;28 days of albendazole 15 mg/kg/day
2 A Pilot Study of Neurocysticercosis Treatment Completed NCT00283699 Phase 3 albendazole
3 Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients Completed NCT00290823 Phase 3 Albendazole;Dexamethasone;Omeprazole
4 Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Completed NCT00441285 Phase 2, Phase 3 Praziquantel;Albendazole;ABZ Placebo;PZQ Placebo
5 Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Recruiting NCT02945527 Phase 2, Phase 3 Acetazolamide;Dexamethasone
6 Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Not yet recruiting NCT02947581 Phase 3 Albendazole and praziquantel;Albendazole and praziquantel placebo
7 RCT ALB for SA Cysticercosis Withdrawn NCT00133458 Phase 3 Albendazole
8 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Completed NCT00527579 Phase 1 [F-18]FBR
9 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Completed NCT00526916 Phase 1 [C-11]PBR28
10 Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Completed NCT02234570 Phase 1 Oxfendazole
11 Single Ascending Dose Safety Study of Oxfendazole Withdrawn NCT01584362 Phase 1 oxfendazole;placebo;oxfendazole;oxfendazole;oxfendazole;oxfendazole;oxfendazole
12 EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso Completed NCT03095339
13 Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis Completed NCT00001912
14 Taenia Solium Control Case Study in Zambia Completed NCT01368354
15 Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis Completed NCT00004403 albendazole;dexamethasone;phenytoin
16 Targeted Screening for Taenia Solium Tapeworms Completed NCT01296958 Niclosamide
17 Treatment of Patients With Cysticercosis With Praziquantel or Albendazole Recruiting NCT00001205
18 Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa? Recruiting NCT02612896 Mass drug administration, praziquantel 10mg/kg
19 People Presenting With Neurocysticercosis in North America Terminated NCT02233855
20 Mass Treatment T Solium Community Study Terminated NCT00138359 Niclosamide

Search NIH Clinical Center for Taeniasis

Genetic Tests for Taeniasis

Anatomical Context for Taeniasis

MalaCards organs/tissues related to Taeniasis:

38
Brain, Testes, Colon

Publications for Taeniasis

Articles related to Taeniasis:

(show top 50) (show all 228)
# Title Authors Year
1
Prevalence of Echinococcus granulosus Taeniasis in Stray Dogs in the Region of Constantine (North-East Algeria). ( 28929396 )
2017
2
Mapping the residual incidence of taeniasis and cysticercosis in Colombia, 2009-2013, using geographical information systems: Implications for public health and travel medicine. ( 29288739 )
2017
3
Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. ( 28449318 )
2017
4
Taeniasis in a Spanish girl. ( 27601094 )
2017
5
Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis. ( 28077749 )
2017
6
Taeniasis caused by Taenia saginata in Gianyar town and Taenia solium in Karangasem villages of Bali, Indonesia, 2011-2016: How to detect tapeworm carriers, anamnesis or microscopy? ( 28634145 )
2017
7
Human taeniasis: current insights into prevention and management strategies in endemic countries. ( 28615981 )
2017
8
A systematic review of taeniasis, cysticercosis and trichinellosis in Vietnam. ( 28320455 )
2017
9
Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis. ( 28892472 )
2017
10
Taeniasis: An Unusual Presentation. ( 28764162 )
2017
11
Taeniasis: A possible cause of ileal bleeding. ( 29291202 )
2017
12
Development of a health education intervention strategy using an implementation research method to control taeniasis and cysticercosis in Burkina Faso. ( 28569208 )
2017
13
Geospatial and age-related patterns of Taenia solium taeniasis in the rural health zone of Kimpese, Democratic Republic of Congo. ( 26996821 )
2016
14
Taeniasis in non-descript dogs in Ngorongoro, Tanzania: Prevalence and predisposing factors. ( 27247069 )
2016
15
Taeniasis vs cysticercosis infection routes. ( 27262080 )
2016
16
Behavioral and hormonal changes associated with the infective dose in experimental taeniasis in golden hamsters (Mesocricetus auratus). ( 27109310 )
2016
17
About human taeniasis and Taenia saginata diagnosis by endoscopy. ( 26984440 )
2016
18
Pathogenesis of Taenia solium taeniasis and cysticercosis. ( 26824681 )
2016
19
AuthorA's answer: About human taeniasis and Taenia saginata diagnosis by endoscopy. ( 27650793 )
2016
20
Cysticercosis/taeniasis endemicity in Southeast Asia: Current status and control measures. ( 26802488 )
2016
21
Taenia solium Taeniasis and Cysticercosis in Southeast Asia. ( 26834197 )
2016
22
Endoscopy as a diagnostic and therapeutic alternative technique of taeniasis. ( 26219408 )
2016
23
GPS Tracking of Free-Ranging Pigs to Evaluate Ring Strategies for the Control of Cysticercosis/Taeniasis in Peru. ( 27035825 )
2016
24
Control of Taenia solium taeniasis/cysticercosis: The best way forward for sub-Saharan Africa? ( 27140860 )
2016
25
Taeniasis among Refugees Living on Thailand-Myanmar Border, 2012. ( 26401787 )
2015
26
A school based cluster randomised health education intervention trial for improving knowledge and attitudes related to Taenia solium cysticercosis and taeniasis in Mbulu district, northern Tanzania. ( 25719902 )
2015
27
On Taeniasis/Cysticercosis Mimicking Lymphoma on PET/CT Imaging. ( 25899585 )
2015
28
Seroprevalence and risk factors of human cysticercosis and taeniasis prevalence in a highly endemic area of epilepsy in Bangoua, west Cameroon. ( 26747010 )
2015
29
Taenia solium taeniasis and cysticercosis control and elimination through community-based interventions. ( 25544938 )
2014
30
On taeniasis, hydatidosis and 'figatellu'. ( 24813526 )
2014
31
Recent situation of taeniasis in Mongolia (2002-2012). ( 24850968 )
2014
32
Immunology of Taenia solium taeniasis and human cysticercosis. ( 24962350 )
2014
33
Prevalence and risk factors for Taenia solium taeniasis in Kaniyambadi block, Tamil Nadu, South India. ( 25116828 )
2014
34
Current status of taeniasis and cysticercosis in Vietnam. ( 24850954 )
2014
35
Rare case of disseminated cysticercosis and taeniasis in a Japanese traveler after returning from India. ( 23629930 )
2013
36
Current status of taeniasis in Thailand. ( 23467328 )
2013
37
Current status and perspectives of cysticercosis and taeniasis in Japan. ( 23467264 )
2013
38
Human taeniasis in the Republic of Korea: hidden or gone? ( 23467688 )
2013
39
Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. ( 23947762 )
2013
40
Correction: Epidemiology and Management of Cysticercosis and Taenia solium Taeniasis in Europe, Systematic Review 1990-2011. ( 24367473 )
2013
41
Current status of human taeniasis in Lao People's Democratic Republic. ( 23710098 )
2013
42
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. ( 23922733 )
2013
43
Intestinal inflammatory pseudotumor caused by taeniasis: Calcareous corpuscles as a diagnostic clue. ( 23530565 )
2013
44
Advances in diagnosis and spatial analysis of cysticercosis and taeniasis. ( 23985371 )
2013
45
Bayesian modelling to estimate the test characteristics of coprology, coproantigen ELISA and a novel real-time PCR for the diagnosis of taeniasis. ( 23464616 )
2013
46
Mini review on chemotherapy of taeniasis and cysticercosis due to Taenia solium in Asia, and a case report with 20 tapeworms in China. ( 23959481 )
2013
47
Therapeutic effect of praziquantel against Taeniasis asiatica. ( 23618773 )
2013
48
A case of taeniasis diagnosed postpartum. ( 23707843 )
2013
49
An imported case of disseminated cysticercosis and taeniasis. ( 22293822 )
2012
50
Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. ( 22336287 )
2012

Variations for Taeniasis

Expression for Taeniasis

Search GEO for disease gene expression data for Taeniasis.

Pathways for Taeniasis

Pathways related to Taeniasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.66 CALR CD40LG CTSL IL10

GO Terms for Taeniasis

Cellular components related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of membrane GO:0016021 9.96 CD40LG CD79A MT-CO1 MT-CYB MT-ND1 RTP1
2 external side of plasma membrane GO:0009897 9.26 CALR CD40LG CD79A TGFBR3
3 mitochondrial respiratory chain complex III GO:0005750 9.16 MT-CO1 MT-CYB
4 respiratory chain GO:0070469 8.8 MT-CO1 MT-CYB MT-ND1

Biological processes related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.46 CALR IL10 MT-CYB MT-ND1
2 response to copper ion GO:0046688 9.26 MT-CO1 MT-CYB
3 B cell differentiation GO:0030183 9.13 CD40LG CD79A IL10
4 B cell proliferation GO:0042100 8.8 CD40LG CD79A IL10

Sources for Taeniasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....